These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8917423)

  • 21. [The influence of sodium thiosulfate on the antitumor effect of cisplatin in human gastric cancer cell lines].
    Fujii T; Saito D; Yoshida S; Ookura H; Oguro Y
    Gan To Kagaku Ryoho; 1988 Dec; 15(12):3227-32. PubMed ID: 3196041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Combination effect of caffeine and cisplatin on a cisplatin resistant human lung cancer cell line].
    Ohsaki Y; Ishida S; Fujikane T; Akiba Y; Osanai S; Onodera S
    Gan To Kagaku Ryoho; 1990 Jul; 17(7):1339-43. PubMed ID: 2369137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The evaluation of gastric cancer sensitivity to 5-FU/CDDP in terms of induction of apoptosis: time- and p53 expression-dependency of anti-cancer drugs.
    Matsuhashi N; Saio M; Matsuo A; Sugiyama Y; Saji S
    Oncol Rep; 2005 Sep; 14(3):609-15. PubMed ID: 16077963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Establishment and drug-resistance gene expression of cisplatin-resistant cell line Tca8113/CDDP].
    Zhou XJ; Li Q; Chen WT
    Shanghai Kou Qiang Yi Xue; 2003 Dec; 12(6):432-5. PubMed ID: 14966583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
    Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
    Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platinum agents in the treatment of osteosarcoma: efficacy of cisplatin vs. carboplatin in human osteosarcoma cell lines.
    Robson H; Meyer S; Shalet SM; Anderson E; Roberts S; Eden OB
    Med Pediatr Oncol; 2002 Dec; 39(6):573-80. PubMed ID: 12376980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Establishment of a cisplatin-induced human hepatocellular carcinoma drug-resistant cell line and its biological characteristics].
    Yang JX; Tang WX
    Ai Zheng; 2002 Aug; 21(8):872-6. PubMed ID: 12478896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transport of cisplatin and bis-acetato-ammine-dichlorocyclohexylamine Platinum(IV) (JM216) in human ovarian carcinoma cell lines: identification of a plasma membrane protein associated with cisplatin resistance.
    Sharp SY; Rogers PM; Kelland LR
    Clin Cancer Res; 1995 Sep; 1(9):981-9. PubMed ID: 9816070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased expression of thioredoxin/adult T-cell leukemia-derived factor in cisplatin-resistant human cancer cell lines.
    Yamada M; Tomida A; Yoshikawa H; Taketani Y; Tsuruo T
    Clin Cancer Res; 1996 Feb; 2(2):427-32. PubMed ID: 9816187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overcoming glutathione S-transferase P1-related cisplatin resistance in osteosarcoma.
    Pasello M; Michelacci F; Scionti I; Hattinger CM; Zuntini M; Caccuri AM; Scotlandi K; Picci P; Serra M
    Cancer Res; 2008 Aug; 68(16):6661-8. PubMed ID: 18701490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic efficacy of a new topoisomerase I and II inhibitor TAS-103, against both P-glycoprotein-expressing and -nonexpressing drug-resistant human small-cell lung cancer.
    Parajuli P; Yano S; Nishioka Y; Nokihara H; Hanibuchi M; Nishimura N; Utsugi T; Sone S
    Oncol Res; 1999; 11(5):219-24. PubMed ID: 10608616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms of resistance in a human cell line exposed to sequential topoisomerase poisoning.
    Saleem A; Ibrahim N; Patel M; Li XG; Gupta E; Mendoza J; Pantazis P; Rubin EH
    Cancer Res; 1997 Nov; 57(22):5100-6. PubMed ID: 9371509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition by 5-fluorouracil of ERCC1 and gamma-glutamylcysteine synthetase messenger RNA expression in a cisplatin-resistant HST-1 human squamous carcinoma cell line.
    Fujishima H; Nakano S; Masumoto N; Esaki T; Tatsumoto T; Kondo T; Niho Y
    Oncol Res; 1997; 9(4):167-72. PubMed ID: 9268987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination chemotherapy of paclitaxel and cisplatin induces apoptosis with Bcl-2 phosphorylation in a cisplatin-resistant human epidermoid carcinoma cell line.
    Sawada S; Mese H; Sasaki A; Yoshioka N; Matsumura T
    Cancer Chemother Pharmacol; 2003 Jun; 51(6):505-11. PubMed ID: 12709826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative analysis of expression levels of bax, bcl-2, and survivin in cancer cells during cisplatin treatment.
    Ikeguchi M; Nakamura S; Kaibara N
    Oncol Rep; 2002; 9(5):1121-6. PubMed ID: 12168083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Possible mechanism responsible for the acquisition of resistance to cis-diamminedichloroplatinum (II) by cultured human testicular seminoma cells.
    Kobayashi T; Fujii T; Jo Y; Kinugawa K; Fujisawa M
    J Urol; 2004 May; 171(5):1929-33. PubMed ID: 15076314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In-vitro effect of a combination of 5-fluorouracil (5-FU) and cisplatin (CDDP) on human gastric cancer cell lines: timing of cisplatin treatment.
    Cho H; Imada T; Oshima T; Shiozawa M; Rino Y; Takanashi Y
    Gastric Cancer; 2002; 5(1):43-6. PubMed ID: 12021859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of naturally acquired multiple-drug resistance of Yoshida rat ascites hepatoma AH66 cell line.
    Miyamoto K; Wakabayashi D; Minamino T; Nomura M; Wakusawa S; Nakamura S
    Anticancer Res; 1996; 16(3A):1235-40. PubMed ID: 8702243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms associated with the expression of cisplatin resistance in a human ovarian tumor cell line following exposure to fractionated X-irradiation in vitro.
    Dempke WC; Shellard SA; Hosking LK; Fichtinger-Schepman AM; Hill BT
    Carcinogenesis; 1992 Jul; 13(7):1209-15. PubMed ID: 1638688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cellular basis for differential sensitivity to cisplatin in human germ cell tumour and colon carcinoma cell lines.
    Sark MW; Timmer-Bosscha H; Meijer C; Uges DR; Sluiter WJ; Peters WH; Mulder NH; de Vries EG
    Br J Cancer; 1995 Apr; 71(4):684-90. PubMed ID: 7710929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.